Resistance to infection/reinfection by Schistosoma mansoni is not augmented by three treatments with 45 days intervals.
Silveira
A M
AM
Universidade do Vale do Rìo Doce, MG, Brasil.
Fraga
L A
LA
Prata
A
A
Correa-Oliveira
R
R
Addiss
D A
DA
Viana
I R
IR
Colley
D G
DG
Gazzinelli
G
G
D000293:Adolescent; D000328:Adult; D000818:Animals; D000977:Antiparasitic Agents / Q000494:pharmacology; D001938:Brazil; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D003430:Cross-Sectional Studies; D005500:Follow-Up Studies; D006801:Humans; D007113:Immunity, Innate; D008875:Middle Aged; D010073:Oxamniquine / Q000494:pharmacology*; D012550:Schistosoma mansoni / Q000187:drug effects* / Q000472:pathogenicity; D012555:Schistosomiasis mansoni / Q000188:drug therapy*
D000977:Antiparasitic Agents; D010073:Oxamniquine